Taranto D, Suozzo R, de Sio I, Romano M, Caporaso N, Del Vecchio Blanco C, Coltorti M
Istituto di Medicina Generale e Metodologia Clinica, First School of Medicine, University of Naples, Italy.
Digestion. 1990;47(1):56-60. doi: 10.1159/000200477.
This study was undertaken to evaluate the effect of metoclopramide on transmural oesophageal variceal pressure and portal blood flow in cirrhotic patients. Sixteen cirrhotics were randomly assigned to metoclopramide (10 mg i.v.) or saline. Metoclopramide significantly decreased transmural variceal pressure (15.7% decrease, p less than 0.05 vs. basal value). In order to evaluate if the metoclopramide-induced drop in transmural variceal pressure was due to an effect on portal haemodynamics, we also measured, by means of real time and pulsed Doppler ultrasonography, portal vein diameter, mean velocity of portal flow, and portal venous flow. No significant change was observed before and after metoclopramide. In conclusion, metoclopramide, which increases lower oesophageal sphincter pressure, significantly decreases transmural variceal pressure in cirrhotic patients. However, it does not have any effect on portal haemodynamics.
本研究旨在评估甲氧氯普胺对肝硬化患者食管壁静脉曲张压力及门静脉血流的影响。16例肝硬化患者被随机分为甲氧氯普胺组(静脉注射10毫克)和生理盐水组。甲氧氯普胺显著降低了食管壁静脉曲张压力(降低15.7%,与基础值相比,p<0.05)。为了评估甲氧氯普胺引起的食管壁静脉曲张压力下降是否归因于对门静脉血流动力学的影响,我们还通过实时脉冲多普勒超声测量了门静脉直径、门静脉平均流速和门静脉血流量。甲氧氯普胺前后未观察到显著变化。总之,增加食管下括约肌压力的甲氧氯普胺可显著降低肝硬化患者的食管壁静脉曲张压力。然而,它对门静脉血流动力学没有任何影响。